Wednesday, 20 March 2019

Blackstone Life Sciences' $250 Million Investment in Anthos Therapeutics - Global Legal Chronicle

Blackstone Life Sciences' $250 Million Investment in Anthos Therapeutics  Global Legal Chronicle

Goodwin advised Anthos Therapeutics Inc. on the deal. Blackstone Life Sciences and Novartis launched Anthos Therapeutics Inc., a new biopharmaceutical ...

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)